COVID19
World warmly welcomes Chinese vaccines
Updated: Feb 1, 2021
chinadaily.com.cn
Print
Share - WeChat
Bahrain
Bahrain's health regulator on Dec 13, 2020, announced it has officially approved the registration of a COVID-19 vaccine developed by the China National Pharmaceutical Group, or Sinopharm, according to Bahrain News Agency.
The National Health Regulatory Authority made the decision to approve and use the vaccine after thorough review and evaluation of the clinical trials data.
Bahrain, which has participated in Phase III clinical trials of the vaccine in August, authorized the emergency use of Sinopharm's vaccine in November to cover those frontline professionals in contact with COVID-19 patients.
Several ministers and senior officials have already received the vaccine in Bahrain, including Bahrain's crown prince.
Xinhua contributed to this story.
MOST POPULAR
- 1 China to give visa-free treatment to another 9 countries
- 2 China fully opens manufacturing sector to foreign investors in landmark opening up move
- 3 China's import expo attracts record-breaking participating countries, exhibitors
- 4 China's door opening even wider to foreign visitors, businesses
- 5 China revises rules to ease foreign strategic investment in listed firms
Editors' Picks
Video:
Peru sees new port open
Infographic:
China's public holidays for 2025
Infographic:
Basic facts of APEC
Infographic:
Wrapping up the 7th CIIE: Data recap
